INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

71,123 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
SH
Stiefel Jennifer D HDirector, President & Secretary
IPSTIP STRATEGY HOLDINGS, INC.
Option exercise
M—
208 sh
Nov 2, 2026Nov 4, 2026
Page 108 of 1779
← PrevNext →
traded Nov 2, 2026
+2d
SEC Form 4

Evidence

13
FJ
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$2,717
7 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

13
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$49K
120 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

13
FL
Flavin LisaSenior VP & CCO
EMREMERSON ELECTRIC CO
Grant or award
A—
14.1K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

13
LA
Lin AlfredDirector
DASHDoorDash, Inc.
Other acquisition or disposition
J—
254.4K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

13
HK
Hooks Michael K.Director
MBUUMALIBU BOATS, INC.
Grant or award
A—
4,562 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

13
KJ
Kasbar Michael JDirector, Executive Chairman
WKCWORLD KINECT CORP
Open-market sale · 10b5-1 plan
SELL$72K
1,938 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

13
CS
Chandra SunilDirector
PFSIPennyMac Financial Services, Inc.
Grant or award
A$32K
550 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

13
PJ
Piazza Nicholas J.Senior VP & CPO
EMREMERSON ELECTRIC CO
Grant or award
A—
12.1K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

13
UA
Utterback Cynthia ADirector
EBMTEagle Bancorp Montana, Inc.
Grant or award
A—
1,232 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

13
CT
Chemodurow TanyaDirector
EBMTEagle Bancorp Montana, Inc.
Grant or award
A—
1,232 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

13
CS
Cape ShavonDirector
EBMTEagle Bancorp Montana, Inc.
Grant or award
A—
1,232 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

13
LR
Linnane Robert13D Group Member
NGVCNatural Grocers by Vitamin Cottage, Inc.
Tax withholding
F$17K
608 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

13
BJ
Baughman Michael JExec VP, CFO & CAO
EMREMERSON ELECTRIC CO
Grant or award
A—
13.8K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

13
RE
Rubin ElaineDirector
DXLGDESTINATION XL GROUP, INC.
Grant or award
A$18K
40.1K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

13
GB
Gordon William BDirector
DUOLDuolingo, Inc.
Open-market sale · 10b5-1 plan
SELL$240K
1,759 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

13
SM
Spaulding MirandaEVP - CFO
EBMTEagle Bancorp Montana, Inc.
Grant or award
A—
2,429 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
LG
Ludwig Jeffrey G.Director, President & CEO
MSBIMidland States Bancorp, Inc.
Tax withholding
F$93K
2,814 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

12
GG
Gemayel GeorgesDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
8,613 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
HM
Hudson Frederick M.Director
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
7,296 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
HM
Hudson Frederick M.Director
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
8,613 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
RL
Runnette Deirdre L.Chief Legal Officer
BMBLBumble Inc.
Tax withholding
F$238K
39.9K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
BC
Barlow CarroleeDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
6,847 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
BP
Bhatt Padmanabh P.Sr. VP of IP, CSO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
100.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
70.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
MA
Merriman Dwight ADirector
MDBMongoDB, Inc.
Open-market sale · 10b5-1 plan
SELL$1.70M
4,846 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
20.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
HM
Hudson Frederick M.Director
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
6,847 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
FR
Fenimore Christopher R.EVP Finance CFO
REGNREGENERON PHARMACEUTICALS, INC.
Gift
G—
15 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
DC
Dec Timothy CSenior Vice-President & CFO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
40.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
DC
Dec Timothy CSenior Vice-President & CFO
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
50.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
MS
Mitra SabyaschiGroup President
EMREMERSON ELECTRIC CO
Tax withholding
F$79K
477 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

12
MF
Mottola FrankSVP, Chief Tech. Ops. Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
3,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
CP
Coghlan John PhilipDirector
LIFLife360, Inc.
Open-market sale · 10b5-1 plan
SELL$83K
1,841 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
3,500 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
BC
Barlow CarroleeDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
2,989 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
GG
Gemayel GeorgesDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
7,296 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
BR
Burchianti RalphDirector
CBFVCB Financial Services, Inc.
Option exercise
M$74K
2,810 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

12
MF
Mottola FrankSVP, Chief Tech. Ops. Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
14.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

12
MF
Mottola FrankSVP, Chief Tech. Ops. Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
20.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence